Invention Grant
US08642548B2 Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
有权
Val（8）GLP-1组合物和治疗功能性消化不良和/或肠易激综合征的方法
- Patent Title: Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
- Patent Title (中): Val（8）GLP-1组合物和治疗功能性消化不良和/或肠易激综合征的方法
-
Application No.: US13389410Application Date: 2010-08-05
-
Publication No.: US08642548B2Publication Date: 2014-02-04
- Inventor: Peter Richardson , Enda Kenny , Per Hellstrom , Marshall L. Grant , Grayson W. Stowell , Scott Daniels , Anthony Smithson , Stephanie Greene
- Applicant: Peter Richardson , Enda Kenny , Per Hellstrom , Marshall L. Grant , Grayson W. Stowell , Scott Daniels , Anthony Smithson , Stephanie Greene
- Applicant Address: US CA Valencia
- Assignee: Mannkind Corporation
- Current Assignee: Mannkind Corporation
- Current Assignee Address: US CA Valencia
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Hal Gibson
- International Application: PCT/US2010/044600 WO 20100805
- International Announcement: WO2011/017554 WO 20110210
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61P3/10 ; A61P7/12 ; C07K14/605
Abstract:
A method of treating functional dyspepsia and/or irritable bowel syndrome in mammals in need of treatment is disclosed herein. The method comprises administering to the mammal a formulation by inhalation, wherein the formulation avoids first pass metabolism of the active ingredient. The method comprises administering a formulation by pulmonary inhalation comprising a diketopiperazine and a glucagon-like peptide (GLP-1), analog, ROSE-010.
Public/Granted literature
- US20120252728A1 Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome Public/Granted day:2012-10-04
Information query
IPC分类:
